Akebia grants new hire stock options for 8,400 shares under Nasdaq inducement plan
AKBA•Akebia Therapeutics granted a newly hired employee options for 8,400 shares on Sept. 30, 2026, with a $0.92 exercise price and a four-year vesting schedule.
1. Option award details
Akebia Therapeutics granted a newly hired employee stock options for 8,400 shares on Sept. 30, 2026. The exercise price is $0.92 per share, equal to the stock’s closing price on the grant date. The options vest over four years, with 25% vesting after one year and the remaining 75% in quarterly installments, subject to continued service. They have a 10-year term under the company’s inducement award program and a related stock option agreement.
